From: NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis
All patients (n = 202) | Sarcoidosis (n = 106) | Hypersensitivity pneumonitis (n = 53) | Other DLDs | ||||
---|---|---|---|---|---|---|---|
All (n = 43) | Organising pneumonia (n = 10) | Pulmonary involvement in connective tissue diseases (n = 25) | Idiopathic pulmonary fibrosis (n = 8) | ||||
Age, years (mean ± SD)* | 46.8 ± 15.8 | 38.7 ± 11.2 | 51.3 ± 16.3 | 61.5 ± 12.0 | 57.9 ± 11.4 | 59.1 ± 11.3 | 73.4 ± 8.2 |
Gender (female/male)† | 118/84 | 60/46 | 32/21 | 26/17 | 5/5 | 20/5 | 1/7 |
Smoking status (no/yes)†† a | 151/48 | 78/26 | 44/9 | 29/13 | 7/2 | 20/5 | 2/6 |
Total cell count b, ×105cells/mL (median, P25-P75)** | 1.7 (0.9–3.3) | 1.6 (0.8–2.8) | 2.8 (1.2–6.1) | 1.4 (0.8–2.4) | 1.6 (0.7–2.4) | 1.2 (0.8–2.5) | 1.5 (1.0–3.6) |
Neutrophils b,% (median, P25-P75)* | 2.8 (1.2–5.8) | 1.6 (1.0–3.0) | 4.8 (2.7–8.2) | 5.8 (2.4–9.8) | 8.7 (5.0–9.9) | 3.6 (1.5–9.8) | 7.2 (4.7–16.5) |
Eosinophils b, % (median, P25-P75)* | 0.6 (0.2–2.0) | 0.4 (0.1–1.0) | 1.6 (0.5–3.7) | 0.8 (0.2–2.8) | 1.6 (0.4–6.5) | 0.4 (0.0–1.5) | 2.5 (1.1–8.7) |
Alveolar macrophages b, % (median, P25-P75)* | 49.2 (34.6–65.2) | 56.0 (37.6–68.7) | 32.4 (22.9–49.0) | 55.2 (42.0–66.4) | 44.1 (28.1–58.2) | 55.8 (43.3–68.2) | 58.6 (44.7–65.3) |
Lymphocytes b, % (median, P25-P75)* | 41.8 (28.0–57.4) | 39.9 (23.9–56.6) | 53.2 (41.0–69.1) | 31.2 (23.8–43.8) | 42.3 (27.6–57.1) | 30.0 (23.7–44.8) | 26.8 (20.1–33.0) |